Back to Journals » OncoTargets and Therapy » Volume 9

Review

The evolution of combined molecular targeted therapies to advance the therapeutic efficacy in melanoma: a highlight of vemurafenib and cobimetinib

       
Total article views   HTML views PDF downloads Totals
8,781 Dovepress* 7,551+ 1,376 8,927
PubMed Central* 1,230 481 1,711
Totals 8,781 1,857 10,638
*Since 22 June 2016
+Since July 2016

View citations on PubMed Central and Google Scholar